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Shear stress-stimulated endothelial cells induce
smooth muscle cell chemotaxis via platelet-derived
growth factor-BB and interleukin-1
Alan Dardik, MD, PhD, Akimasa Yamashita, MD, PhD, Faisal Aziz, MD, Hidenori Asada, MD,
and Bauer E. Sumpio, MD, PhD, New Haven and West Haven, Conn
Objective: Vascular smooth muscle cell (SMC) migration is critical to the development of atherosclerosis and neointimal
hyperplasia. Hemodynamic forces such as shear stress and cyclic strain stimulate endothelial cell signal-transduction
pathways, resulting in the secretion of several factors, including SMC chemoattractants such as platelet-derived growth
factor (PDGF). We hypothesized that mechanical forces stimulate endothelial cells to secrete SMC chemoattractants to
induce migration via the mitogen-activated protein kinase (MAPK) pathway.
Methods: Bovine aortic endothelial cells were exposed to shear stress, cyclic strain, or static conditions for 16 hours. The
resulting conditioned mediumwas used as a SMC chemoattractant in a Boyden chamber. Activation of SMC extracellular
signal-regulated protein kinase 1/2 (ERK1/2) was assessed by Western blot analysis. Pathways were inhibited with
anti-PDGF-BB or anti-interleukin-1 (IL-1) antibodies, or the ERK1/2 upstream pathway inhibitor PD98059.
Results: Conditioned medium from endothelial cells exposed to shear stress corresponding to arterial levels of shear stress
stimulated SMC migration but lower levels of shear stress or cyclic strain did not. Both PDGF-BB and IL-1 were
secreted into the conditioned medium by endothelial cells stimulated with shear stress. Both PDGF-BB and IL-1
stimulated SMC chemotaxis but were not synergistic, and both stimulated SMCERK1/2 phosphorylation. Inhibition of
PDGF-BB or IL-1 inhibited SMC chemotaxis and ERK1/2 phosphorylation.
Conclusion: Shear stress stimulates endothelial cells to secrete several SMC chemoattractants, including PDGF-BB and
IL-1; both PDGF-BB and IL-1 stimulate SMC chemotaxis via the ERK1/2 signal-transduction pathway. These
results suggest that the response to vascular injury may have a common pathway amenable to pharmacologic manipula-
tion. (J Vasc Surg 2005;41:321-31.)
Clinical Relevance:One difficulty in the pharmacologic treatment of atherosclerosis or neointimal hyperplasia leading to
restenosis is the multiplicity of activated pathways and thus potential treatment targets. This study demonstrates that
shear stress, a hemodynamic force that may be a biologically relevant stimulus to induce vascular pathology, stimulates
endothelial cells to secrete PDGF-BB and IL-1. Both of these mediators stimulate the SMC ERK1/2 pathway to induce
migration, a critical event in the pathogenesis of atherosclerosis and neointimal hyperplasia. Therefore, this study
suggests a relevant common target pathway in SMC that is amenable to manipulation for clinical treatment.Vascular smooth muscle cell (SMC) proliferation and
migration from the media to the intima are critical events in
the development of atherosclerosis and neointimal hyper-
plasia. SMC proliferation and migration are regulated by
several factors, including cytokines that may be released by
cells within the vessel wall or from cells circulating within
the blood.1-3
Platelet-derived growth factor (PDGF) is a strong che-
moattractant for SMC migration and is produced by endo-
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been shown to be required for accumulation of SMC in the
neointima in the rat balloon-injury model6-7 and may stim-
ulate SMC migration by inducing phosphorylation and
activation of SMC mitogen-activated protein kinase
(MAPK) intracellular signaling pathways.8-10
Although the entire blood vessel is subjected to hemo-
dynamic forces such as blood pressure and cyclic strain,
only endothelial cells are ordinarily exposed to shear stress,
the lateral frictional force of the flowing blood on the
endothelial cell apical membrane. Hemodynamic forces
induce endothelial cell proliferation, cytoskeletal reorgani-
zation, growth factor production, MAPK signal transduc-
tion, phosphatidylinositol-3=-kinase (PI3K) signal trans-
duction, as well as activation of other endothelial cell
intracellular pathways.11-15 The endothelial cell response to
hemodynamic forces may result in the synthesis and secre-
tion of SMC mitogens and chemoattractants.16-19 In par-
ticular, several studies have demonstrated that exposure of
endothelial cells to laminar shear stress or cyclic strain
induces PDGF-A and -B chain mRNA expression in
12,20-22vitro.
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ways, such as the mammalian target of rapamycin pathway,
leading to expression of pp70s6 kinase, the protein kinase
B/Akt pathway, and the Sma- and Mad-related protein
pathway, as well as endothelial cell production of nitric
oxide and integrins.23-25 We hypothesized that shear stress
stimulates endothelial cells to synthesize and secrete several
proteins, including and in addition to PDGF, that stimulate
SMC chemotaxis. We examined interleukin-1 (IL-1)
because it is secreted by endothelial cells in response to
shear stress, stimulates SMC migration, and stimulates the
SMC extracellular signal-regulated protein kinase (ERK)
1/2 pathway, as does PDGF-BB. We report that endothe-
lial cells secrete PDGF-BB and IL-1 in response to shear
stress, and that both PDGF-BB and IL-1 secreted by
endothelial cells in response to shear stress stimulate SMC
chemotaxis by the ERK1/2 pathway.
MATERIALS AND METHODS
Cell culture. Bovine aortic endothelial cells and SMC
were obtained from freshly killed calves at a local slaughter-
house, as previously described.26 In brief, endothelial cells
were obtained by gently scraping the intimal surface of the
thoracic aorta. SMC were obtained by cleaning the aorta of
intima and adventitia, mincing it into small pieces, and
culturing in 10% fetal bovine serum (FBS) until the SMC
migrated away from the tissue.
Cells were maintained in Dulbecco modified Eagle
medium F-12 (GIBCO BRL, Gaithersburg, Md), supple-
mented with 10% FBS (Hyclone Laboratories, Logan,
Utah), 5 g/mL deoxycytidine (Sigma Chemical, St.
Louis, Mo), 5 g/mL thymidine (Sigma Chemical), and
antibiotics (penicillin, 100 U/mL; streptomycin, 100 g/
mL; and amphotericin B, 250 ng/mL, GIBCO BRL).
Cells were grown to confluence at 37°C in a humidified
incubator with 5% carbon dioxide.
Endothelial cells were identified by their typical cobble-
stone appearance and indirect immunofluorescence stain-
ing for factor VIII antigen and lack of SMC -actin stain-
ing. SMC were identified by their typical hill and valley
morphology and by indirect immunofluorescent staining
for -actin and lack of endothelial cell factor VIII staining.
Cell populations were more than 99% pure for all
samples. Cells used in this study were between passages 3 to
9. Cells were synchronized prior to hemodynamic force
exposure by being incubated in serum-free media (SFM)
for 48 hours.
Shear stress and cyclic strain application. Endothelial
cells were seeded on 6-well plates coated with collagen I,
without any SMC, and treated with 30 or 210 rpm oscilla-
tory shear stress for 1 to 16 hours by using an orbital shaker
(DS-500, VWR International, West Chester, Penn), as
previously described.23,27-28 A frequency of oscillation of
30 rpm produces approximately 0.5 dyne/cm2 shear stress,
and a frequency of 210 rpm produces approximately 9.8
dyne/cm2 shear stress at the bottom of a single well in a
standard 6-well culture plate23,27; measurement of these
values with optical velocimetry confirmed that frequencies
of oscillation of 30 or 210 rpm produce less than 0.1
dyne/cm2 or 11.1 dyne/cm2, respectively, in our orbitalshaker (unpublished data). These measurements corre-
spond to published reports that a frequency of oscillation of
200 rpm corresponds to arterial levels (11.5 dynes/cm2) of
shear stress.23
Some endothelial cells were seeded on flexible silicone
membranes coated with collagen I (Flexcell International
Corp, McKeesport, Penn). Cyclic strain was applied by
using a Flexercell Strain Unit (Flexcell FX-2000; Flexcell
International Corp) with 150 mm Hg of vacuum, which
produces an average strain of 10% at a frequency of 60
cycles/min, for 16 hours at 37°C.11
Conditioned medium (CM) was collected after 1 to 16
hours of exposure to shear stress or cyclic strain, or from
control cells exposed to static conditions, and used as a
chemoattractant for SMCmigration. In some experiments,
actinomycin D (10 g/mL) was included in the medium
overlying the endothelial cells for the 4 hours prior to CM
collection to determine whether shear stress stimulated
endothelial cell protein synthesis.
SMC migration assay. A modified Boyden 48-well
microchemotaxis chamber with a polycarbonate
polyvinylpyrrolidone-free membrane with 8-micrometer
pores (NeuroProbe Inc, Gaithersburg, Md) was used as
previously described.29 In the lower chamber, 30 L of
CM or control media (10% FBS, SFM, or SFM containing
PDGF-AA, PDGF-BB, IL-1, or IL-1ra [human recombi-
nant; Calbiochem, La Jolla, Calif]) was placed as a che-
moattractant. The cell suspension (50,000 SMC in 50 L
SFM) was placed in the top chamber, and the Boyden
chamber was incubated at 37°C for 4 hours. The mem-
brane was removed, fixed in 70% ethyl alcohol, stained with
hematoxylin, and mounted on a slide. The cells on the
upper surface were mechanically removed, and the cell
nuclei remaining on the undersurface of the filter were
counted under high power magnification (400) for five
fields per well.
In migration inhibition experiments, neutralizing anti-
bodies against PDGF-AA, PDGF-BB, IL-1, IL-1 recep-
tor, insulin like growth factor-1 (IGF-1), heparin-binding
epidermal growth factor-like growth factor (HB-EGF),
transforming growth factor- (TGF-) (Calbiochem), or
antiphospho ERK1/2 (Cell Signaling, Beverly, Mass) were
added to the chemoattractant at various concentrations.
For MAPK inhibition studies, PD98059 or dimethyl
sulfoxide (DMSO) (Calbiochem) was diluted in SFM (10
mol/L)10,30 and preincubated with SMC for 30 minutes
at 37°C prior to placement in the Boyden chamber.
PDGF-BB, IL-1 measurement. The concentration
of PDGF-BB or IL-1 was measured by using an enzyme-
linked immunosorbent assay (ELISA) kit (R&D Systems,
Minneapolis, Minn) according to the manufacture’s in-
structions. The optical density at 405 nm was measured by
using a microplate spectrophotometer (Dynatech Labora-
tories Inc, Indianapolis, Ind). Four samples were measured
in each group.
ERK1/2 determination. SMCwere exposed to SFM,
CM, PDGF-BB (0.5 ng/mL), or IL-1 (0.1 pg/mL) for 30
minutes. For the MAPK inhibition studies, PD98059 or
DMSO was diluted in SFM (10 mol/L) and preincubated
with SMC for 1 hour at 37°C. After stimulation, SMC were
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and scraped in lysis buffer containing 50 mmol/L HEPES
(pH7.4), 150mmol/LNaCl, 10%glycerol, 1%TritonX-100,
1.5 mmol/L MgCl2, 1 mmol/L sodium pyrophosphate, 1
mmol/L sodium orthovanadate, 10 g/mL leupeptin, 10
g/mL aprotinin, and 1 mmol/L phenylmethylsulfonyl flu-
oride.
The cell extracts were centrifuged at 15,000g for 10
minutes. The supernatant was collected and protein con-
tent measured by the Bradford method. Laemmli sample
buffer was added to equivalent protein amounts of each
sample, followed by boiling for 5 minutes. Samples were
resolved by 10% sodium dodecylsulfate-polyacrylamide gel
electrophoresis and transferred to nitrocellulose mem-
brane. The blots were incubated in 5% nonfat dry milk with
antibodies to antiphospho ERK1/2 or anti-total ERK1/2
(Cell Signaling), prior to detection of immunoreactivity by
enhanced chemiluminescence (Amersham Life Science Inc,
Arlington Heights, Ill).
Statistical analysis. Data were calculated for each
group as mean  SEM and were compared by analysis of
variance; selected subgroups were compared by using the
Scheffé post hoc test. The data were computed with the
StatView 5.0.1 software (SAS Institute Inc, Cary, NC); P 
.05 was considered significant.
RESULTS
CM stimulates SMC migration. To determine
whether shear stress stimulates endothelial cell secretion of
SMC chemoattractants, endothelial cells were exposed to
shear stress for 16 hours in SFM and then the CM was
collected and used as a chemoattractant for SMC migra-
tion. SMC migration was stimulated by medium condi-
tioned by endothelial cells exposed to shear stress, corre-
sponding to arterial levels of shear stress (CM 210 rpm), to
a similar degree as 10% FBS or PDGF-BB
(Fig 1, A). Medium conditioned by endothelial cells not
exposed to shear stress (CM static), low levels of shear stress
(CM 30 rpm), cyclic strain (CM cyclic strain), or medium
containing PDGF-AA alone, did not significantly stimulate
SMC migration (Fig 1, A).
Medium conditioned by shear stress, corresponding to
arterial levels of shear stress (CM 210 rpm), that was either
boiled or freeze-thawed lost the ability to stimulate SMC
migration (data not shown), suggesting that proteins se-
creted into the CM were responsible for attracting SMC
migration. In addition, CM that was passed through a
0.2-micrometer pore filter had the same ability to stimulate
SMC migration as unfiltered CM (data not shown), sug-
gesting that proteins were secreted into the CM and were
not attached to potentially broken pieces of cell mem-
branes, and thus the shear stress treatment did not damage
the endothelial cells.
To determine the time course of protein secretion, CM
was collected after 1 to 16 hours to determine its ability to
attract SMCmigration; SMCmigration was stimulated to a
greater extent by endothelial cells exposed to shear stress
(SS-CM), compared with endothelial cells exposed to static
conditions (static-CM), by as early as 1 hour (Figure 1, B).
However, maximal SMC attraction was achieved by 16hours, suggesting that endothelial cells secrete proteins
into the CM in response to shear stress, both upon initial
exposure as well as several hours later.
To determine whether shear stress stimulated endothe-
lial cell protein synthesis, endothelial cells were preincu-
bated with actinomycin D (10 g/mL) for 4 hours prior to
medium collection after 4 or 16 hours of shear stress
exposure. The ability of CM to attract SMC migration was
unchanged at 4 hours in the presence of actinomycin D,
whereas this ability was decreased at 16 hours (Fig 1, C),
suggesting that shear stress stimulates endothelial cell pro-
tein synthesis and secretion of proteins into the CM by 16
hours, whereas secretion of protein at earlier time points
may be due to release of previously synthesized proteins.
PDGF-BB stimulates SMC migration. Because
shear stress stimulates endothelial cells to secrete PDGF-
BB, and PDGF-BB is a potent SMC chemoattractant, we
determined whether SMC migration induced by shear
stress-CM was due to PDGF-BB secreted into the CM by
endothelial cells exposed to shear stress. An ELISA assay
was used to directly measure PDGF-BB secreted into the
medium; endothelial cells exposed to shear stress, corre-
sponding to arterial levels of shear stress (210 rpm), se-
creted more PDGF-BB into the CM compared with endo-
thelial cells exposed to static conditions (0 rpm), low levels
of shear stress (30 rpm), or cyclic strain (Figure 2, A). To
determine whether PDGF-BB in the CM was physiologi-
cally active, neutralizing antibodies to PDGF-BB were
added to medium conditioned by endothelial cells exposed
to shear stress and SMC migration determined. Anti-
PDGF-BB antibody inhibited SMC migration in a dose-
dependent fashion, whereas anti-PDGF-AA did not; anti-
PDGF-BB (10 g/mL) inhibited SMCmigration induced
by CM by 37% and inhibited SMC migration induced by
PDGF-BB (5 ng/mL) by 82% (Fig 2, B).
IL-1 stimulates SMC migration. Because anti-
PDGF-BB inhibited CM-induced SMC migration by only
37% compared with 82% inhibition of PDGF-BB–induced
SMC migration, it was possible that the CM contained
additional factors that stimulated SMC migration other
than PDGF-BB. To determine whether additional SMC
chemoattractants were present in CM, an excess amount of
neutralizing antibodies directed against other cytokines
known to be secreted by endothelial cells in response to
shear stress and that stimulate SMC migration were also
added individually to the CM. Antibodies against IL-1
inhibited SMC migration; however, excess amounts of
antibodies against IGF-1, HB-EGF, or TGF- (10 g/
mL) did not inhibit SMCmigration (data not shown). The
inhibition of CM-induced SMC migration by anti-IL-1
was dose-dependent, with maximal inhibition (62%) occur-
ring with 10 ng/mL anti-IL-1 (Fig 2, C).
Since IL-1 is known to be biologically active at very
low (picomolar) concentrations, and low concentrations of
anti-IL-1 inhibited SMC migration induced by CM, low
concentrations of IL-1 were tested as a chemoattractant
for SMC migration in the absence of serum or conditioned
medium. IL-1 stimulated SMC migration in a dose-de-
pendent fashion, with maximal stimulation of migration at
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migration attracted by CM (Fig 3, A). Identical concentra-
tions of IL-1ra, an inactive form of IL-1, did not stimulate
SMC migration (Fig 3, A). As this concentration of IL-1
was below the limit of detection of an IL-1 ELISA, the
concentration of IL-1 used to attract SMC migration was
Fig 1. Shear stress-stimulated endothelial cell-derived
(SMC) chemotaxis. A, Stimulation of SMC migration in
to medium conditioned by shear stress (SS), correspondi
(FBS 10%, PDGF-BB) was significant compared with sta
.05); medium conditioned by low levels of SS (CM 30 rpm
PDGF-BB and PDGF-AA were 0.5 ng/mL, in SFM (
platelet-derived growth factor). B, SMC migration in res
due to CM obtained under static (0 rpm, static-CM) an
.0001, ANOVA) as is the difference over time (P .00
protein synthesis after 16 but not 4 hours. The differen
groups receiving actinomycin D or not, is significant (timconfirmed by ELISA prior to dilution (data not shown).Antibodies to IL-1 inhibited the SMC migration stimu-
lated by IL-1, whereas a similar isotype but unrelated
antibody did not inhibit IL-1–induced SMC migration
(Fig 3, B). Similarly, an antibody to the IL-1 receptor also
inhibited IL-1–induced SMC migration (Fig 3, B).
Because IL-1 stimulated SMC migration to a slightly
itioned medium (CM) stimulates smooth muscle cell
nse to CM. The increase in SMC migration in response
arterial levels of SS (CM 210 rpm), or positive controls
nditions (SFM or CM static) or PDGF-AA (n3, *P 
cyclic strain (CMCS) did not stimulate SMCmigration.
serum-free medium; FBS, fetal bovine serum; PDGF,
e to CM is time-dependent. The difference in migration
conditions (210 rpm, SS-CM) is significant (n  7, P
C, SMCmigration in response to CM depends on SMC
SMC migration due to SS-CM, at 16 hours, between
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and IL-1 did not stimulate SMC migration beyond the
response to either one alone (Fig 3, C). Similarly, inhibition
Fig 2. Conditioned medium stimulates smooth muscle
(PDGF-BB) and interleukin-1 (IL-1). A, Enzyme-lin
PDGF-BB concentration (pg/mL) in serum-free mediu
medium (CM) under static conditions (0 rpm), 30 rpm
hours. The difference between the amount of PDGF-BB
 4; *P  .02, ANOVA). B, Dose-dependent inhibition
AA. Inclusion of anti-PDGF-BB (10 g/mL) decreased
to PDGF-BB (5 ng/mL; n  3; *P  .0001, ANOV
neutralizing antibodies (0 to 10 ng/mL) directed agains
anti-IL-1 (n  4, *P  .0006, ANOVA).of SMC migration induced by CM was inhibited slightlyless by antibodies to IL-1 than by antibodies to PDGF-
BB, and simultaneous use of both antibodies did not result
in a further decrease in SMC migration (Fig 3, C). These
(SMC) migration via platelet-derived growth factor-BB
immunoabsorbent assay (ELISA) determination of the
FM), fetal bovine serum (FBS) (10%), or conditioned
10 rpm shear stress (SS), or cyclic strain (CS), after 16
M 210 rpm and the other groups of CM is significant (n
C migration with anti-PDGF-BB but not anti-PDGF-
migration 37% in response to CM and 82% in response
, Dose-dependent inhibition of SMC migration with








t IL-results suggest lack of synergy between the ability of
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therefore, PDGF-BB and IL-1 may stimulate identical
Fig 3. Interleukin-1 (IL-1) stimulates smooth musc
SMC migration with IL-1. Maximal SMC migration
ANOVA); identical concentration of IL-1ra produced no
induced SMCmigration. IL-1–induced SMCmigration
4, P .0006, ANOVA) but not in the presence of a simi
induced SMC migration was also inhibited in the presen
antiphospho extracellular signal-regulated protein kinase
inhibit SMC migration. The inclusion of IL-1 (0.1 pg
induced by PDGF-BB (0.5 ng/mL) alone (11% increase
ng/mL) produced no additional inhibition of SMCmigr
ng/mL) alone (1% decrease; n  5, P .99).intracellular signaling pathways leading to SMCmigration.CM, PDGF-BB, and IL-1 stimulate SMC chemo-
taxis via ERK1/2. To determine whether the SMC
ll (SMC) migration. A, Dose-dependent stimulation of
rred in response to 0.1 pg/mL (n  5, P  .0001,*
ation (n 4, P .023, ANOVA).B, Specificity of IL-1
inhibited in the presence of anti-IL-1 (10 ng/mL, n
type antibody (anti-P-ERK, 10 ng/mL; p.34). IL-1
f anti-IL-1 receptor (p.005, ANOVA) (anti-P ERK,
Lack of synergy of PDGF-BB and IL-1 to stimulate or
) produced no additional SMC migration beyond that
3, P  .99, ANOVA). The inclusion of anti-IL-1 (10









ationERK1/2 pathway is the mechanism for SMC migration
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bated with PD98059, an upstream inhibitor of the MAPK
ERK1/2 pathway, or vehicle alone, prior to attraction of
migration. CM-stimulated SMC migration was inhibited
36% in the presence of PD98059 but not in the presence of
vehicle alone (Fig 4). Similarly, PDGF-BB–stimulated
SMC migration was inhibited 39% and IL-1–stimulated
SMC migration was inhibited 33% in the presence of
PD98059 (Fig 4). These results suggest that the ERK1/2
pathway mediates SMCmigration induced by CM, PDGF-
BB, or IL-1.
SMC ERK1/2 phosphorylation was directly assessed
by Western blot analysis after exposure to PDGF-BB,
IL-1, or CM. PDGF-BB, IL-1, and CM (210 rpm) all
stimulated SMC phosphorylation of ERK1/2 (Fig 5), but
medium conditioned with low levels of shear stress (30
rpm) or conditioned with cyclic strain did not stimulate
ERK1/2 phosphorylation (data not shown). Phosphoryla-
tion due to PDGF-BB was inhibited in the presence of
antibodies to PDGF-BB but not PDGF-AA, and phos-
phorylation due to IL-1 was inhibited in the presence of
antibody to IL-1 (Fig 5). Phosphorylation of SMC
ERK1/2 that was stimulated by CM (210 rpm) was re-
duced in the presence of antibodies to either PDGF-BB or
to IL-1 (Fig 5). These results suggest that PDGF-BB and
IL-1 in the CM stimulate the SMC ERK1/2 pathway.
DISCUSSION
We demonstrate that shear stress stimulates endothelial
cells to synthesize and secrete PDGF-BB and IL-1, both of
which stimulate SMC chemotaxis via the MAPK ERK1/2
Fig 4. Inhibition of smooth muscle cell (SMC) chemota
upstream pathway-inhibitor PD98059. Inclusion of PD
conditioned medium (CM) (n 3, P .004, ANOVA),
P  .002), or IL-1 (0.1 pg/mL; P  .01).pathway. Neither low levels of shear nor cyclic strain stimulateendothelial cells to secrete these chemoattractants. These data
suggest that hemodynamic forces can stimulate endothelial
cells to secrete soluble factors that may act in a paracrine
fashion on SMC to stimulate chemotaxis.
Hemodynamic forces are known to play a role in the
pathogenesis of atherosclerosis and neointimal hyperplasia.
Under normal arterial conditions, laminar shear stress is
one of the factors responsible for maintenance of the qui-
escent endothelial cell phenotype in vivo. Conversely, alter-
ations in shear stress, such as disturbed or turbulent flow
induced by endothelial injury or loss or by a physiologic or
iatrogenic repair process, activate endothelial cells and lead
to the common response characterized by atherosclerosis
and neointimal hyperplasia.15
Mechanisms of how shear stress affects endothelial cell
signal transduction are becoming increasingly understood.
In vitro studies have demonstrated activation of the MAPK
signaling pathways in endothelial cells in response to shear
stress.25,26,31 Shear stress also activates the transcription
factor egr-1 in endothelial cells27,32-33 that stimulates ad-
ditional gene transcription and may lead to secretion of
soluble factors such as PDGF-B, fibroblast growth factor-2
(FGF-2), and TGF-1.12,20,21,35-36
PDGF is a family of signaling molecules important for
cell growth and motility and consists of disulfide-linked
dimers of polypeptides A, B, C, and D; five isoforms have
been identified so far (AA, AB, BB, CC, and DD).2 PDGF
isoforms exert their effects on target cells by binding and
activating two structurally related but differing affinity pro-
tein tyrosine kinase receptors ( and ); PDGF-AA binds to
the PDGF- receptor alone, whereas PDGF-BB binds to
y extracellular signal-regulated protein kinase (ERK1/2)
9 (10 mol/L) inhibited SMC migration stimulated by
let-derived growth factor-BB ( PDGF-BB) (0.5 ng/mL;xis b
9805
platethe PDGF-, -, and - receptors.2,37 Vascular SMC
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PDGF-AA.5,8,37-39 We confirm PDGF-BB, but not
PDGF-AA, stimulates SMC chemotaxis in our model, and
we detect slightly lower, but similar, levels of PDGF-BB
secreted into the CM as reported using a similar model.39
We extend these observations and report that shear stress,
but not cyclic strain, stimulates endothelial cells to release
PDGF-BB, confirming the differential effects of these he-
modynamic forces on endothelial cells.40
Additional factors can modulate PDGF-BB–stimulated
SMC chemotaxis; for example, PDGF-AA and FGF-2 each
inhibit PDGF-BB–stimulated chemotaxis.5,41 Our finding
that anti-PDGF-BB antibody only partially inhibited SMC
chemotaxis towards CM, compared with almost complete
inhibition of chemotaxis towards PDGF-BB (Fig 2, B),
suggests that additional factors may be present in the CM
that modulate the effect of PDGF-BB. Other factors, such
as IGF-1, HB-EGF, TGF-, or IL-1, are known to be
secreted by endothelial cells and stimulate SMC chemotax-
is42,43; of these factors, only IL-1 activity was detected in
the CM. However, it is possible that these antibodies did
not recognize bovine isoforms of these substances, so their
lack of reactivity does not exclude their presence in the CM.
In addition, other factors may also be present in the CM
that affect SMC migration, such as plasminogen activator
inhibitor-1.44 Vascular endothelial growth factor activity
may also be present in the CM (data not shown).
IL-1 and IL-1, the two isoforms of the proinflam-
Fig 5. Smoothmuscle cell (SMC) extracellular signal-regu
endothelial cell conditioned medium, platelet-derived grow
graph represents mean of phosphorylated ERK1/
* P .05 compared with control conditions. The photom
ERK1/2 bands on Western blot; total ERK1/2 bands de
stimulated SMC ERK1/2 phosphorylation was also inhib
PDGF-BB was 0.5 ng/mL; IL-1 was 0.1 pg/mL. Anti-Pmatory cytokine IL-1, have identical biologic effects inmost studies.45,46 IL-1 is regulated independently of
IL-1 but is thought to be the major form that is biologi-
cally active as its precursor form is cleaved by caspase-1
(IL-1–converting enzyme) to be secreted in its active form,
whereas IL-1 typically remains cell-associated or mem-
brane-associated. Both IL-1 and IL-1 exert their bio-
logic effects by binding to the type I IL-1 receptor, a
member of the Toll-like receptor superfamily.47,48 Binding
of IL-1 to the type I IL-1 receptor results in the formation
of a complex with the IL-1 receptor accessory protein,and
ultimately initiates signal transduction. However, binding
of IL-1 to the type II receptor (which lacks a cytoplasmic
domain), binding to the soluble IL-1 receptor, or compet-
itive inhibition from IL-1ra (a naturally secreted but inac-
tive form of IL-1) inhibit IL-1 signaling and may serve to
regulate the pathway in vivo.45 IL-1 receptor signaling
stimulates several intracellular pathways, including the
MAPK ERK1/2 pathway that is necessary for activation of
the iNOS and NF-B pathways.49,50
IL-1 is mitogenic for vascular SMC, although not
during the short time course of the experiments reported
here51; the effect of IL-1 on SMC proliferation may be due
to modulation of PDGF-BB activity and signaling.52 In
addition, PDGF can regulate IL-1 receptor levels and en-
hances, through an ERK1/2 dependent mechanism, IL-1–
induced activation of NF-B and iNOS expression.53
ERK1/2 is a member of the MAPK signaling family that
is known to play a role in vascular biology.26,54-56 Although
protein kinase (ERK1/2) phosphorylation is stimulated by
tor-BB (PDGF-BB), and interleukin-1 (IL-1). The bar
ormalized to total ERK1/2 bands (n  3).
raph shows a representative experiment of phosphorylated
trated equivalent loading (data not shown). Shear stress-
in the presence of PD98059 (10 M, data not shown).
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in SMC migration.10,58 Our results confirm the activity of this
pathway in migration stimulated by PDGF-BB, IL-1, or
CM, but do not exclude the presence of additional factors in
the CM that may stimulate ERK1/2 or modulate PDGF or
IL-1 activity (Fig 4). In addition, PDGF or IL-1 may
stimulate other intracellular pathways that stimulate chemo-
taxis, such as the MAPK p38 or jnk pathways, or the PI3K,
Akt, and phospholipase C-	 pathways.3,39,59
We examined the ERK1/2 pathway as this pathway is
activated by both PDGF-BB and IL-1 and induces SMC
migration.10 We used PD98059, a small cell-permeable
molecule that is a specific inhibitor of MAPK kinase-1
(MEK)30 as PD98059 does not inhibit p70 S6 kinase,
phospholipase C, Raf-kinase, cAMP-dependent kinase,
protein kinase C, v-Src, EGF receptor kinase, PDGF recep-
tor kinase, or PI3K at the concentrations used in this
study.10,60 Although the use of chemical inhibitors is less
specific than some techniques used to inhibit signal trans-
duction, such as the use of dominant negative mutations,
PD98059 has similar specificity to antisense oligonucleo-
tides10; nevertheless, it is possible that PD98059 inhibits
other intracellular signal transduction pathways.
We used the orbital shaker to generate oscillatory shear
stress on the endothelial cell monolayer,23,27,28 because it
allows collection of CMmore easily than do other methods
of generating shear stress such as the parallel plate appara-
tus. The small volume of medium in a culture well allows
detection of low concentrations of secreted chemoattrac-
tants such as IL-1.
Palumbo et al39 used a cone-and-plate apparatus to
expose endothelial cells to laminar shear stress; the resulting
CM produced maximal SMC migration at 5 dyne/cm2,
with less migration at 15 dyne/cm2. We report maximal
SMC migration at 210 rpm, which may reflect differences
in oscillatory and laminar shear stress effect on endothelial
cells, including release of other factors in addition to
PDGF-BB.
Although the orbital shaker does not produce uniform
laminar shear stress on the endothelial cells, most of the




where a is the radius of orbital rotation (0.95 cm),  is the
culture medium density (0.997 g/mL),  is the medium
viscosity (0.0101 poise), and f is the frequency of rotation
(rotations/sec).23 At 210 rpm, the frequency of rotation used
inmost of these experiments, calculated 
max is 9.8 dyne/cm
2,
which is similar to the value that we measured (11.1 dyne/
cm2) as well as the values reported by others (11.5 dyne/cm2)
to be equivalent to arterial levels of shear stress in vivo. 23
This model cannot account for the presence of other
cell types, such as platelets, monocytes, and macrophages
that may affect SMCmigration in vivo. In addition, the role
of cell-cell contact between endothelial cells and SMC is
not assessed by use of CM, which may be important for the
mechanism of action of IL-1 in vivo.61 Our finding thatlow magnitudes of shear stress conditioning produce less
SMC chemotaxis than higher levels of shear stress (Fig 1,
A) may be a limitation of this model, especially since the
temporal variation in shear stress in this model may not
reflect that of the cardiac cycle in vivo.62 However, our data
support a role for hemodynamic forces such as shear stress
inducing SMCmigration, at physiologically relevant levels,
at least by affecting the overlying endothelial monolayer.
Hemodynamic forces such as shear stress may stimulate
endothelial cells to secrete SMC chemoattractants such as
PDGF-BB and IL-1, which act on deeper layers of the
vessel wall in a paracrine or juxtacrine fashion to subse-
quently stimulate SMC signal transduction and cell migra-
tion. Since signal transduction pathways stimulated by
shear stress may converge on common pathways, pharma-
cologic manipulation of a common pathway may allow
control of the response to vascular injury.
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Nie and Jacek Paszkowiak. We acknowledge the inspiration
and support of the E.J. Wylie Memorial Traveling Fellow-
ship, Lifeline Foundation (AD).
REFERENCES
1. Ross R. The pathogenesis of atherosclerosis–an update. N Engl J Med
1986;314:488-500.
2. Heldin CH, Westermark B. Mechanism of action and in vivo role of
platelet-derived growth factor. Physiol Rev 1999;79:1283-316.
3. Uchida K, Sasahara M, Morigami N, Hazama F, Kinoshita M. Expres-
sion of platelet-derived growth factor B-chain in neointimal smooth
muscle cells of balloon injured rabbit femoral arteries. Atherosclerosis.
1996;124:9-23.
4. Ross R, Raines EW, Bowen-Pope DF. The biology of platelet-derived
growth factor. Cell 1986;46:155-69.
5. Koyama N, Morisaki N, Saito Y, Yoshida S. Regulatory effects of
platelet-derived growth factor-AA homodimer on migration of vascular
smooth muscle cells. J Biol Chem 1992;267:22806-12.
6. Ferns GA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R.
Inhibition of neointimal smooth muscle accumulation after angioplasty
by an antibody to PDGF. Science 1991;253:1129-32.
7. Hart CE, Kraiss LW, Vergel S, Gilbertson D, Kenagy R, Kirkman T, et al.
PDGFbeta receptor blockade inhibits intimal hyperplasia in the baboon.
Circulation 1999;99:564-9.
8. Kundra V, Escobedo JA, Kazlauskas A, KimHK, Rhee SG,Williams LT,
et al. Regulation of chemotaxis by the platelet-derived growth factor
receptor-. Nature 1994;367:474-6.
9. Jiang B, Yamamura S, Nelson PR, Mureebe L, Kent KC. Differential
effects of platelet-derived growth factor isotypes on human smooth
muscle cell proliferation and migration are mediated by distinct signal-
ing pathways. Surgery 1996;120:427-32.
10. Graf K, Xi XP, Yang D, Fleck E, Hsueh WA, Law RE. Mitogen-
activated protein kinase activation is involved in platelet-derived growth
factor-directed migration by vascular smooth muscle cells. Hyperten-
sion 1997;29:334-9.
11. Sumpio BE, Banes AJ, Levin LG, Johnson G Jr. Mechanical stress
stimulates aortic endothelial cells to proliferate. J Vasc Surg 1987;6:
252-6.
12. Malek AM, Gibbons GH, Dzau VJ, Izumo S. Fluid shear stress differ-
entially modulates expression of genes encoding basic fibroblast growth
factor and platelet-derived growth factor B chain in vascular endothe-
lium. J Clin Invest 1993;92:2013-21.
13. Gimbrone MA, Nagel T, Topper JN. Biomechanical activation: an
emerging paradigm in endothelial adhesion biology. J Clin Invest
1997;99:1809-13.
JOURNAL OF VASCULAR SURGERY
February 2005330 Dardik et al14. Chien S, Li S, Shyy JYJ. Effects of mechanical forces on signal transduc-
tion and gene expression in endothelial cells. Hypertension 1998;31(2):
162-9.
15. Garcia-Cardena G, Comander J, Anderson KR, Blackman BR, Gimbrone
MA. Biomechanical activation of vascular endothelium as a determinant of
its functional phenotype. Proc Natl Acad Sci 2001;98:4478-85.
16. Davies PF. Flow-mediated endothelial mechanotransduction. Physiol
Rev 1995;75:519-60.
17. Lehoux S, Tedgui A. Signal transduction of mechanical stresses in the
vascular wall. Hypertension 1998;32:338-45.
18. Traub O, Berk BC. Laminar shear stress: mechanisms by which endo-
thelial cells transduce an atheroprotective force. Arterioscler Thromb
Vasc Biol 1998;18:677-85.
19. Gimbrone MA. Vascular endothelium, hemodynamic forces, and
atherogenesis. Am J Pathol 1999;155:1-5.
20. Hsieh HJ, Li NQ, Frangos JA. Shear stress increases endothelial platelet-
derived growth factor mRNA levels. Am J Physiol 1991;260:H642-6.
21. Mitsumata M, Fishel RS, Nerem RM, Alexander RW, Berk BC. Fluid
shear stress stimulates platelet-derived growth factor expression in
endothelial cells. Am J Physiol 1993;265:H3-8.
22. Sumpio BE,DuW,Galagher G,Wang X, Khachigian LM, Collins T, et al.
Regulation of PDGF-B in endothelial cells exposed to cyclic strain. Arte-
rioscler Thromb Vasc Biol 1998;18:349-55.
23. Kraiss LW, Weyrich AS, Alto NM, Dixon DA, Ennis TM,Modur V, et al.
Fluid flow activates a regulator of translation, p70/p85 S6 kinase, in
human endothelial cells. Am J Physiol Heart Circ Physiol 2000;278:
H1537-44.
24. Dimmeler S, Assmus B,Hermann C,Haendeler J, Zeiher AM. Fluid shear
stress stimulates phosphorylation of Akt in human endothelial cells: in-
volvement in suppression of apoptosis. Circ Res 1998;83:334-41.
25. Go YM, Boo YC, Park H, Maland MC, Patel R, Pritchard KA Jr, et al.
Protein kinase B/Akt activates c-JunNH2-terminal kinase by increasing
NO production in response to shear stress. J Appl Physiol 2001;91:
1574-81.
26. Azuma N, Duzgun SA, Ikeda M, Kito H, Akasaka N, Sasajima T, et al.
Endothelial cell response to different mechanical forces. J Vasc Surg
2000;32:789-94.
27. Yun S, Dardik A, Haga M, Yamashita A, Yamaguchi S, Koh Y, et al.
Transcription factor Sp1 phosphorylation induced by shear stress inhib-
its membrane type 1-matrix metalloproteinase expression in endothe-
lium. J Biol Chem 2002;277(38):34808-14.
28. HagaM, Yamashita A, Paszkowiak J, Sumpio BE, Dardik A. Oscillatory
shear stress increases smooth muscle cell proliferation and Akt phos-
phorylation. J Vasc Surg 2003;37:1277-84.
29. Nesselroth SM,Willis AI, Fuse S, Olson ET, Lawler J, Sumpio BE, et al.
The C-terminal domain of thrombospondin-1 induces vascular smooth
muscle cell chemotaxis. J Vasc Surg 2001;33:595-600.
30. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. PD98059 is
specific inhibitor of the activation of mitogen-activated protein kinase in
vitro and in vivo. J Biol Chem 1995;270:27489-94.
31. Takahashi M, Berk BC. Mitogen-activated protein kinase (ERK1/2)
activation by shear stress and adhesion in endothelial cells: Essential role
for a herbimycin-sensitive kinase. J Clin Invest 1996;98:2623-31.
32. Khachigian LM, Anderson KR, Halnon NJ, GimbroneMA Jr, Resnick N,
Collins T. Egr-1 is activated in endothelial cells exposed to fluid shear stress
and interacts with a novel shear-stress-response element in the PDGF
A-chain promoter. Arterioscler Thromb Biol 1997;17:2280-6.
33. Chiu JJ, Wung BS, Hsieh HJ, Lo LW,Wang DL. Nitric oxide regulates
shear stress-induced early growth response-1: expression via the extra-
cellular signal-regulated kinase pathway in endothelial cells. Circ Res
1999;85:238-46.
34. Resnick N, Collins T, Atkinson W, Bonthron DT, Dewey CF Jr,
Gimbrone MA Jr. Platelet-derived growth factor B chain promoter
contains a cis-acting fluid shear-stress-responsive element. Proc Natl
Acad Sci 1993;90:4591-5.
35. Mondy JS, Lindner V, Miyashiro JK, Berk BC, Dean RH, Geary RL.
Platelet-derived growth factor ligand and receptor expression in re-
sponse to altered blood flow in vivo. Circ Res 1997;81:320-7.
36. Lum RM, Wiley LM, Barakat AI. Influence of different forms of fluid
shear stress on vascular endothelial TGF-beta1 mRNA expression. Int J
Mol Med 2000;5(6):635-41.37. Heldin CH, Ostman A, Ronnstrand L. Signal transduction via platelet-
derived growth factor receptors. Biochim Biophys Acta 1998;1378:
F79-113.
38. Koyama N, Hart CE, Clowes AW. Different functions of the platelet-
derived growth factor-alpha and -beta receptors for the migration and
proliferation of cultured baboon smooth muscle cells. Circ Res 1994;
75(4):682-91.
39. PalumboR, Gaetano C, Antonini A, Pompilio G, Bracco E, Ronnstrand
L, et al. Different effects of high and low shear stress on platelet-derived
growth factor isoform release by endothelial cells: consequences for
smooth muscle cell migration. Arterioscler Thromb Vasc Biol 2002;22:
405-11.
40. Haga M, Chen A, Gortler D, Dardik A, Sumpio BE. Shear stress and
cyclic strain may suppress apoptosis in endothelial cells by different
pathways. Endothelium 2003;10(3):149-57.
41. Facchiano A, De Marchis F, Turchetti E, Facchiano F, Guglielmi M,
Denaro A, et al. The chemotactic and mitogenic effects of platelet-
derived growth factor-BB on rat aorta smooth muscle cells are inhibited
by basic fibroblast growth factor. J Cell Sci 2000;113 (Pt 16):2855-63.
42. Abedi H, Zachary I. Signalling mechanisms in the regulation of vascular
cell migration. Cardiovasc Res 1995;30:544-56.
43. Sterpetti AV, Cucina A, Morena AR, Di Donna S, D’Angelo LS,
Cavalarro A, et al. Shear stress increases the release of interleukin-1 and
interleukin-6 by aortic endothelial cells. Surgery 1993;114(5):911-4.
44. Redmond EM, Cullen JP, Cahill PA, Sitzmann JV, Stefansson S,
Lawrence DA. Endothelial cells inhibit flow-induced smooth muscle
cell migration: role of plasminogen activator inhibitor-1. Circulation
2001;103:597-603.
45. Dinarello CA. Interleukin-1. Cytokine Growth Factor Rev 1997;8(4):
253-65.
46. Sims JE. IL-1 and IL-18 receptors, and their extended family. Curr
Opin Immunol 2002;14(1):117-22.
47. Bowie A, O’Neill LA. The interleukin-1 receptor/Toll-like receptor
superfamily: signal generators for pro-inflammatory interleukins and
microbial products. J Leukoc Biol 2000;67(4):508-14.
48. Daun JM, Fenton MJ. Interleukin-1/Toll receptor family members:
receptor structure and signal transduction pathways. J Interferon Cyto-
kine Res 2000;20(10):843-55.
49. Jiang B, Brecher P. N-Acetyl-L-cysteine potentiates interleukin-1beta
induction of nitric oxide synthase : role of p44/42 mitogen-activated
protein kinases. Hypertension 2000;35(4):914-8.
50. Jiang B, Brecher P, Cohen RA. Persistent activation of nuclear factor-
kappaB by interleukin-1beta and subsequent inducible NO synthase
expression requires extracellular signal-regulated kinase. Arterioscler
Thromb Vasc Biol 2001;21(12):1915-20.
51. Libby P, Warner SJ, Friedman GB. Interleukin 1: a mitogen for human
vascular smooth muscle cells that induces the release of growth-inhibitory
prostanoids. J Clin Invest 1988;81(2):487-98.
52. Nathe TJ, Deou J,Walsh B, Bourns B, Clowes AW,DaumG. Interleukin-
1beta inhibits expression of p21(WAF1/CIP1) and p27(KIP1) and en-
hances proliferation in response to platelet-derived growth factor-BB in
smooth muscle cells. Arterioscler Thromb Vasc Biol 2002;22(8):1293-8.
53. JiangB,Xu S, Brecher P,CohenRA.Growth factors enhance interleukin-1
beta-induced persistent activation of nuclear factor-kappa B in rat vascular
smoothmuscle cells. Arterioscler ThrombVasc Biol 2002;22(11):1811-6.
54. Hu Y, Cheng L, Hochleitner BW, Xu Q. Activation of mitogen-
activated protein kinases (ERK/JNK) and AP-1 transcription factor in
rat carotid arteries after balloon injury. Arterioscler Thromb Vasc Biol
1997;17(11):2808-16.
55. Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase
signal transduction pathways activated by stress and inflammation.
Physiol Rev 2001;81:807-69.
56. Yamashita A, Hanna AK, Hirata S, Dardik A, Sumpio BE. Antisense basic
fibroblast growth factor alters the time course ofmitogen-activated protein
kinase in arterialized vein graft remodeling. J Vasc Surg 2003;37:866-873.
57. Bornfeldt KE, Raines EW, Nakano T, Graves LM, Krebs EG, Ross R.
Insulin-like growth factor-I and platelet-derived growth factor-BB in-
duce directed migration of human arterial smooth muscle cells via
signaling pathways that are distinct from those of proliferation. J Clin
Invest 1994;93(3):1266-74.
JOURNAL OF VASCULAR SURGERY
Volume 41, Number 2 Dardik et al 33158. Kundra V, Anand-Apte B, Feig LA, Zetter BR. The chemotactic re-
sponse to PDGF-BB: evidence of a role for Ras. J Cell Biol 1995;130:
725-31.
59. Higaki M, Sakaue H, Ogawa W, Kasuga M, Shimokado K. Phosphatidyl-
inositol 3-kinase-independent signal transduction pathway for platelet-
derived growth factor-induced chemotaxis. J Biol Chem 1996;271:
29342-6.
60. ServantMJ, Giasson E,Meloche S. Inhibition of growth factor-induced
protein synthesis by a selective MEK inhibitor in aortic smooth muscle61. Powell RJ, Bhargava J, Basson MD, Sumpio BE. Coculture conditions
alter endothelial modulation of TGF-beta 1 activation and smooth
muscle growth morphology. Am J Physiol 1998;274:H642-9.
62. Bao X, Clark CB, Frangos JA. Temporal gradient in shear-induced
signaling pathway: involvement of MAP kinase, c-fos, and connexin43.
Am J Physiol Heart Circ Physiol 2000;278:H1598-605.cells. J Biol Chem 1996;271(27):16047-52. Submitted Sep 15, 2004; accepted Nov 8, 2004.
CORRECTION
In: “Prevalence, anatomic patterns, valvular competence, and clinical significance of the Giacomini vein”
(Delis KT, Knaggs AL, and Khodabakhsh P. J Vasc Surg 2004;40:1174-83).
On page 1176, Fig 1 is incorrect. The following is the correct figure:
Great Saphenous Vein (33%)





Great Saphenous Vein (42%)




Profunda Femoral Vein (11%)
BA
Fig 1. Schematic representation of thigh extension (Giacomini vein) of small saphenous vein (SSV) in limbs with a
typical saphenopopliteal junction (A) and in limbs with a high or a very high SSV termination (B). See Methods for
definitions. Epitomized are the single or multiple endings (see Table III) of Giacomini vein. Percentage attached to
named veins represents cumulative occurrence in limbs with (A) a typical saphenopopliteal junction alone (236 of 301;
great saphenous vein, 33% [78 of 236]; posterior thigh muscle veins, 17% [40 of 236]; femoral vein, 8% [19 of 236];
popliteal vein, 100% [236 of 236]) and (B) with a high or a very high SSV termination alone (65 of 301; great
saphenous vein, 42% [27 of 65]; profunda femoral vein, 11% [7 of 65]; posterior thigh muscle veins, 27% [18 of 65];
femoral vein, 14% [9 of 65]). Differences in cumulative proportions not statistically significant. (Please note the possible
extension of Giacomini vein at the top of the thigh.) Giac V; Giacomini vein.
